418 related articles for article (PubMed ID: 25422154)
1. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
[TBL] [Abstract][Full Text] [Related]
2. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
Zandberga E; Zayakin P; Ābols A; Pūpola D; Trapencieris P; Linē A
Cancer Biol Ther; 2017 Aug; 18(8):596-605. PubMed ID: 28665755
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
5. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
Chen Z; Ai L; Mboge MY; Tu C; McKenna R; Brown KD; Heldermon CD; Frost SC
PLoS One; 2018; 13(7):e0199476. PubMed ID: 29965974
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells.
Li Y; Wang H; Oosterwijk E; Tu C; Shiverick KT; Silverman DN; Frost SC
Cancer Invest; 2009 Jul; 27(6):613-23. PubMed ID: 19367501
[TBL] [Abstract][Full Text] [Related]
9. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
Robertson N; Potter C; Harris AL
Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
[TBL] [Abstract][Full Text] [Related]
10. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer.
Ong CHC; Lee DY; Lee B; Li H; Lim JCT; Lim JX; Yeong JPS; Lau HY; Thike AA; Tan PH; Iqbal J
Breast Cancer Res; 2022 Jun; 24(1):38. PubMed ID: 35659359
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
[TBL] [Abstract][Full Text] [Related]
13. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
[TBL] [Abstract][Full Text] [Related]
14. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
Güttler A; Theuerkorn K; Riemann A; Wichmann H; Kessler J; Thews O; Bache M; Vordermark D
Oncol Rep; 2019 Apr; 41(4):2585-2594. PubMed ID: 30720123
[TBL] [Abstract][Full Text] [Related]
15. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB
Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
Potter CP; Harris AL
Br J Cancer; 2003 Jul; 89(1):2-7. PubMed ID: 12838292
[TBL] [Abstract][Full Text] [Related]
18. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL
Endocr Relat Cancer; 2006 Sep; 13(3):921-30. PubMed ID: 16954440
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells.
McDonald PC; Dedhar S
Subcell Biochem; 2014; 75():255-69. PubMed ID: 24146383
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]